There were 136 press releases posted in the last 24 hours and 400,998 in the last 365 days.

Public Notification: XtraHRD Contains Hidden Drug Ingredient

[2/8/2018] Update: This product has been recalled by Organic Herbal Supply, Inc. See the company’s press release for more information.

[1-26-2017] The Food and Drug Administration (FDA) is advising consumers not to purchase or use XtraHRD, a product promoted and sold for sexual enhancement on various Web sites, including www.amazon.com, and possibly in some retail stores.Image of XtraHRD

 

FDA laboratory analysis confirmed that XtraHRD contains N-desmethyl tadalafil. N-desmethyl tadalafil is an analogue of tadalafil, the active ingredient in Cialis, an FDA- approved prescription drug for erectile dysfunction (ED). This undeclared ingredient may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Men with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

Health care professionals and patients are encouraged to report adverse events or side effects related to the use of this product to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Note: This notification is to inform the public of a growing trend of dietary supplements or conventional foods with hidden drugs and chemicals. These products are typically promoted for sexual enhancement, weight loss, and body building and are often represented as being “all natural.” FDA is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients. Consumers should exercise caution before purchasing any product in the above categories. 

Please refer to the links below for more information:

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.